N. G. Brunner, M.D., (Member); T. Namba, M.D.; D. Grob, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
The effect of short, intensive courses of methylprednisolone (60 mg, intramuscularly, daily for 10 days) or corticotrophin (100 units, intravenously, daily for 10 days) was studied in 11 patients with severe generalized myasthenia gravis. A decrease in strength and response to anticholinesterase medication occurred during 30 (71%) of 42 courses of methylprednisolone and during 26 (93%) of 28 courses of corticotrophin. After cessation of each course of hormone, marked improvement in strength and response to anticholinesterase medication above the initial level occurred after 23 (55%) courses of methylprednisolone for an average of 78 days and after 16 (57%) courses of
Learn more about subscription options.
Register Now for a free account.
Brunner NG, Namba T, Grob D. Use of Corticoid in the Management of Severe Generalized Myasthenia Gravis and Comparison with Corticotropin.. Ann Intern Med. 1971;74:838. doi: 10.7326/0003-4819-74-5-838_2
Download citation file:
Published: Ann Intern Med. 1971;74(5):838.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only